CBD-rich cannabis extracts appeared more effective than purified CBD for epilepsy, requiring lower doses with fewer side effects
A meta-analysis of 670 patients from observational studies found that CBD-rich whole-plant extracts had higher seizure improvement rates than purified CBD (71% vs 46%), required lower doses (6.0 vs 25.3 mg/kg/day), and caused fewer adverse effects, supporting the entourage effect hypothesis.
Quick Facts
What This Study Found
Researchers pooled data from 11 observational studies involving 670 patients with treatment-resistant epilepsy to compare CBD-rich extracts to purified CBD products.
Overall, 64% of patients (399/622) reported seizure improvement.
CBD-rich extracts were associated with significantly better outcomes:
- 71% improvement rate (318/447) vs 46% for purified CBD (81/175), p < 0.0001.
- Lower average dose needed: 6.0 mg/kg/day vs 25.3 mg/kg/day.
- Fewer mild adverse effects: 33% vs 76%, p < 0.0001.
- Fewer severe adverse effects: 2.2% vs 12.6%, p < 0.0001 (note: rates of severe AEs with purified CBD corrected).
The authors attributed the difference to synergistic effects of CBD with other phytocompounds (the entourage effect), though they noted this needs confirmation in controlled trials.
Key Numbers
670 patients, 11 studies. CBD-rich extracts: 71% improvement, 6.0 mg/kg/day mean dose, 33% mild AEs. Purified CBD: 46% improvement, 25.3 mg/kg/day mean dose, 76% mild AEs. Both differences highly significant (p < 0.0001).
How They Did This
Meta-analysis of 11 observational clinical studies. 670 patients with treatment-resistant epilepsy. Fischer test for categorical comparisons. Treatment duration 3-12 months (mean 6.2 months). Doses ranged 1-50 mg/kg/day.
Why This Research Matters
This is the first systematic comparison of whole-plant CBD extracts versus purified CBD for epilepsy. If the entourage effect is real, it means the pharmaceutical approach of isolating single compounds may sacrifice efficacy. The 4-fold dose difference has practical implications for cost and side effects.
The Bigger Picture
The pharmaceutical model has focused on purified CBD (Epidiolex) because it is easier to study, standardize, and regulate. This meta-analysis suggests that whole-plant extracts may work better at lower doses, raising questions about whether the regulatory preference for single-compound drugs is optimal for cannabis therapeutics.
What This Study Doesn't Tell Us
All observational studies, not randomized trials. Different formulations, doses, and patient populations across studies. Selection bias likely (patients choosing whole-plant may differ from those using purified). Retrospective data quality varies. The entourage effect is proposed but not directly tested.
Questions This Raises
- ?Would a head-to-head randomized trial confirm the advantage of whole-plant extracts?
- ?Which specific non-CBD compounds contribute to the entourage effect?
- ?Can standardized whole-plant extracts be developed for clinical use?
Trust & Context
- Key Stat:
- CBD-rich extracts: 71% improvement at 6 mg/kg/day vs purified CBD: 46% at 25 mg/kg/day
- Evidence Grade:
- Moderate. Meaningful comparison across multiple studies with large combined sample, but observational design and heterogeneous formulations limit causal conclusions.
- Study Age:
- Published in 2018. The debate between whole-plant extracts and purified CBD continues, with regulatory frameworks still favoring single-compound products.
- Original Title:
- Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.
- Published In:
- Frontiers in neurology, 9, 759 (2018)
- Database ID:
- RTHC-01783
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
What is the entourage effect in this context?
The entourage effect is the idea that CBD works better when accompanied by other cannabis plant compounds (minor cannabinoids, terpenes, flavonoids) than when used alone. This study found CBD-rich extracts worked better at lower doses than purified CBD, which is consistent with synergistic effects from additional plant compounds.
Should patients switch from Epidiolex to whole-plant CBD?
This observational meta-analysis suggests potential advantages of whole-plant extracts, but it was not a controlled trial. Epidiolex has the advantage of standardized dosing and FDA approval. Any treatment changes should be discussed with the treating neurologist.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01783APA
Pamplona, Fabricio A; da Silva, Lorenzo Rolim; Coan, Ana Carolina. (2018). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.. Frontiers in neurology, 9, 759. https://doi.org/10.3389/fneur.2018.00759
MLA
Pamplona, Fabricio A, et al. "Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.." Frontiers in neurology, 2018. https://doi.org/10.3389/fneur.2018.00759
RethinkTHC
RethinkTHC Research Database. "Potential Clinical Benefits of CBD-Rich Cannabis Extracts Ov..." RTHC-01783. Retrieved from https://rethinkthc.com/research/pamplona-2018-potential-clinical-benefits-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.